ZURICH, Nov 29 (Reuters) – Shares in Swiss biotech company
Actelion plunged on Tuesday after a report the company
was not actively considering selling itself, but instead
weighing a “complicated…
The post Actelion shares plunge on report it eyes “complicated” J&J deal appeared first on NASDAQ.